NARDINI, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 7.166
EU - Europa 4.688
AS - Asia 3.827
SA - Sud America 426
Continente sconosciuto - Info sul continente non disponibili 136
AF - Africa 67
OC - Oceania 4
Totale 16.314
Nazione #
US - Stati Uniti d'America 7.004
IT - Italia 1.845
GB - Regno Unito 1.121
CN - Cina 1.120
SG - Singapore 1.079
SE - Svezia 451
HK - Hong Kong 383
VN - Vietnam 345
BR - Brasile 316
DE - Germania 297
TR - Turchia 229
BD - Bangladesh 226
UA - Ucraina 188
FI - Finlandia 179
FR - Francia 153
RU - Federazione Russa 124
KR - Corea 119
IN - India 97
CA - Canada 80
NL - Olanda 69
BG - Bulgaria 64
AR - Argentina 45
MX - Messico 42
ID - Indonesia 34
PL - Polonia 28
IQ - Iraq 27
IE - Irlanda 23
IR - Iran 22
ES - Italia 21
LT - Lituania 20
IL - Israele 18
PK - Pakistan 18
BE - Belgio 17
ZA - Sudafrica 17
CO - Colombia 16
JP - Giappone 15
SA - Arabia Saudita 14
AT - Austria 13
AE - Emirati Arabi Uniti 12
CH - Svizzera 12
EU - Europa 12
EC - Ecuador 11
SI - Slovenia 11
CL - Cile 10
CR - Costa Rica 9
EG - Egitto 9
JM - Giamaica 9
MA - Marocco 9
MY - Malesia 9
TH - Thailandia 9
DZ - Algeria 8
VE - Venezuela 8
JO - Giordania 7
PY - Paraguay 7
UZ - Uzbekistan 7
BY - Bielorussia 6
DK - Danimarca 6
CZ - Repubblica Ceca 5
GR - Grecia 5
KE - Kenya 5
PE - Perù 5
PH - Filippine 5
RS - Serbia 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
HN - Honduras 4
KZ - Kazakistan 4
NI - Nicaragua 4
PA - Panama 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
AL - Albania 3
AU - Australia 3
BO - Bolivia 3
ET - Etiopia 3
GE - Georgia 3
GT - Guatemala 3
LB - Libano 3
NG - Nigeria 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CU - Cuba 2
CY - Cipro 2
EE - Estonia 2
KG - Kirghizistan 2
LV - Lettonia 2
MG - Madagascar 2
MK - Macedonia 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
QA - Qatar 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
GA - Gabon 1
HR - Croazia 1
Totale 16.179
Città #
Southend 832
Santa Clara 830
Singapore 729
Ashburn 634
Woodbridge 496
Fairfield 433
Chandler 429
Hong Kong 374
Jacksonville 354
Hefei 332
Houston 266
Ann Arbor 260
Beijing 246
Nyköping 246
Dearborn 234
San Jose 227
Wilmington 197
Seattle 175
Milan 171
London 158
Rome 157
Cambridge 150
Dallas 146
Los Angeles 123
Izmir 120
Seoul 117
Helsinki 114
New York 98
Ho Chi Minh City 89
The Dalles 87
Council Bluffs 86
Buffalo 80
Hanoi 77
Naples 73
Princeton 70
San Diego 63
Sofia 62
Eugene 61
Chicago 59
Frankfurt am Main 57
Modena 56
Lauterbourg 54
Shanghai 51
Des Moines 39
Moscow 37
Bari 36
Munich 36
São Paulo 36
Bologna 35
Palermo 33
Florence 32
Orem 25
Atlanta 24
Da Nang 24
Philadelphia 24
Chennai 23
Brescia 22
Turin 22
Guangzhou 21
Toronto 21
Catania 20
Dublin 20
Mexico City 18
Brussels 16
Columbus 16
Elk Grove Village 16
Haiphong 16
Redwood City 16
Salt Lake City 16
Boardman 15
Phoenix 15
San Mateo 15
Augusta 14
Memphis 14
Vancouver 14
Warsaw 14
Amsterdam 13
Baghdad 13
Falkenstein 13
Jakarta 13
Montreal 13
Mumbai 13
Ottawa 13
Rio de Janeiro 13
Stockholm 13
Manassas 12
Nanjing 12
Norwalk 12
Tampa 12
Brooklyn 11
Genoa 11
Kent 11
Parma 11
Tokyo 11
Falls Church 10
Johannesburg 10
Kunming 10
Mashhad 10
Treviso 10
Verona 10
Totale 10.698
Nome #
Un raro caso di prostatite da Candida albicans, Candida krusei ed Enterococcus fecium 1.874
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 363
18Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients 347
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: A long follow-up experience 319
Mitochondrial DNA Haplogroups and Highly Active Antiretroviral Therapy–Related Lipodystrophy 317
Molecular Imaging of Vascular Calcification with 18 F-Sodium-Fluoride in Patients Infected with Human Immunodeficiency Virus 311
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. 310
Long-term psychometric outcomes of facial lipoatrophy therapy: Forty-eight-week observational, nonrandomized study 309
Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study 305
Detectable HIV viral load is associated with metabolic syndrome 297
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 295
Autologous fat transfer for treating facial wasting in HIV body fat redistribution syndrome. 287
Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens. 285
Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: Monarch randomized controlled trial 281
Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection 280
Severity of lipodystrophy is associated with decreased health-related quality of life 274
Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy 273
Autologous fat transfer for treating facial wasting in HIV-related lipodystrophy: experience of 53 treated patients 271
Effectiveness and durability of polyacrylamide hydrogel injections for treating HIV-related facial lipoatrophy 269
Autologous fat transfer for the treatment of HIV-related face lipoatrophy: 1-year follow-up 268
Monitoraggio di infezione da Citomegalovirus (CMV)nel paziente sottoposto a trapianto di intestino 257
Prevalence of and risk factors for pubic lipoma development in HIV-infected persons 257
Psychometric evaluation of patients undergoing surgical treatment of HIV-related facial lipoatrophy 256
Age-related comorbidities in people living with HIV 253
Prospective, partially randomized, 24-week study to compare the efficacy and durability of different surgical techniques and interventions for the treatment of HIV-related facial lipoatrophy 246
Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIV 242
Morphologic alterations in HIV infected people with lipodystropy are associated with good adherence to HAART. 231
Does lipodistrophy affect quality of life? 225
Autologous fat transfer for treating facial waisting in HIV body fat redistribution Syndrome 224
Effectiveness and long-term durability of autologous fat transplant for HIV-related face lipoatrophy. 222
Body Image perception in HIV infected women with body fat redistribution. 221
Candidemia nosocomiale: quattro anni di esperienza in un'ospedale universitario italiano 219
Psychometric evaluation in patients undergoing fillers injections for the treatment of HIV-related facial lipoatrophy: polylactic acid versus polyacrylamide 218
Efficacy and safety of medical and surgical interventions for treating HIV-related lipodystrophy in women 217
Long-term follow-up of graft hypertrophy after autologous fat transfer for HIV-related face lipoatrophy (hamster syndrome 1 year later) 208
Long lasting psycho-social benefits of polyacrylamide injections for the treatment of facial lipoatrophy 208
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study 203
How do frailty mediate pathway leading to disability 203
Quality of life and body image in the assessment of psychological impact of lipodystrophy: validation of the italian version of assessment of body change and distress questionnaire 201
Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011 201
Does change of the liver change the metabolism? Assessment of atazanavir pharmacokinetic profile in 7 HIV-infected patients pre- and post-liver transplantation 200
The role of virological and immunological parameters on the diagnosis of metabolic syndrome in HIV-associated lipodystrophy 197
È possibile un counselling HIV su internet? 196
Pregnancy outcomes and cytomegalovirus DNAemia in HIV-infected pregnant women with CMV 194
Virologic failure and metabolic syndrome in patients with HIV infection 194
Different dose adjustments of immunosuppresants are necessary after initiating boosted or unboosted first protease inhibitors regimen post-liver transplantation 190
Validity of body image perception in women with HIV. 188
Limited occurrence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study. 186
Virologic failure and metabolic syndrome in patients with HIV infection 186
Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial 183
Mechanical and ultrasound-assisted liposuction for treating subcutaneous fat accumulations in HIV-related lipodystrophy: experience of 33 treated patients 180
Prevalence and risk factors of pubic lipomas in HIV-infected patients 179
Relapse of HIV-related buffalo hump after liposuction 175
Prospective, 48 weeks follow up, multidisciplinary interventionalstudy to assess improvement of adherence in people with lipodistrophy. 173
Limited occurence of new grade 3-4 toxicity events with salvage regimens based on raltegravir and /or maraviroc: 96 weeks data from the ISS NIA cohort study 167
Qual è il rapporto tra qualità di vita e lipodistrofia 163
HIV counselling looks for new target and methods web versus face to face counselling 163
Ruolo della chirurgia plastica nel trattamento della sindrome da ridistribuzione del tessuto adiposo 158
Lipodystrophy and quality of life: a prospective study 158
Nuovi obiettivi e strumenti di lavoro nel counselling HIV: studio prospettico osservazionale del counselling informatico versus il counselling vis a vis 149
Metabolic and anthropometric alterations in a population of HIV infected patients with a high prevalence of lipodystrophy: associations with HCV coinfection 147
Gender differences in depression evolution in a cohort of patients attendine a metabolic clinic for lipodystrophy management 139
Tenofovir treatment in HIV-related lipodystrophy syndrome. Retrospective observational forty-eight weeks follow-up study 137
Lipodistrophy is related to adherence to antiretroviral therapy (ARV) 134
HIV counselling and prevention on the WEB 131
Totale 16.314
Categoria #
all - tutte 55.282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.282


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022966 0 158 63 98 29 51 41 75 104 78 149 120
2022/20231.483 150 127 119 114 129 204 38 156 195 45 111 95
2023/20241.036 64 72 79 129 149 81 97 106 36 50 57 116
2024/20252.944 117 69 73 227 624 427 221 127 337 97 294 331
2025/20265.021 335 235 509 561 579 402 507 273 544 428 360 288
2026/2027228 174 54 0 0 0 0 0 0 0 0 0 0
Totale 16.314